Clinical Trials Logo

Filter by:
NCT ID: NCT00262366 Completed - Clinical trials for Obstructive Sleep Apnea Syndrome

Comparison of Automatic CPAP to Fixed CPAP for OSAS Following a Prediction Formula

Start date: May 2005
Phase: N/A
Study type: Interventional

Comparison of automatic CPAP with fixed CPAP in patients with OSAS

NCT ID: NCT00261976 Completed - Psoriasis Clinical Trials

A Long-term Safety Study of Infliximab (Remicade)

Start date: February 2002
Phase: Phase 4
Study type: Observational

This is a study evaluating the long-term safety of infliximab (Remicade)

NCT ID: NCT00261950 Completed - Clinical trials for Secondary Hyperparathyroidism

Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease

BONAFIDE
Start date: May 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of cinacalcet on markers of bone turnover in patients with kidney disease who are receiving dialysis.

NCT ID: NCT00259870 Completed - Schizophrenia Clinical Trials

SB-773812 Administered In Adults With Schizophrenia

Start date: September 2005
Phase: Phase 2
Study type: Interventional

This is a two part study designed to evaluate the safety and efficacy of SB-773812 in the treatment of acute schizophrenia. Subjects with acute schizophrenia will be randomized in an adaptive design study to receive placebo, SB-773812 60mg or olanzapine 15mg for 12 weeks in Part A. An interim analysis will be conducted to assess the efficacy and safety of the SB-773812 60mg dose compared with placebo. Based on these data, up to two further doses of SB-773812 will be added to the randomization for Part B.

NCT ID: NCT00259506 Completed - Clinical trials for Recurrent Depression

Implementation and Evaluation of "Mindfulness-Based Cognitive Therapy" in a Health Care Region in Flanders: a Randomized Clinical Trial

Start date: March 2006
Phase: N/A
Study type: Interventional

Research project regarding the possibility to implement and the efficacy of a non-drug, psychotherapeutic intervention (MBCT), in preventing relapse/recurrence of depression.

NCT ID: NCT00259428 Completed - Atrial Fibrillation Clinical Trials

EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)

EURIDIS
Start date: November 2001
Phase: Phase 3
Study type: Interventional

To assess the efficacy of dronedarone versus placebo for the maintenance of normal sinus rhythm after electrical, pharmacological or spontaneous conversion of atrial fibrillation/atrial flutter (AF/AFL). To assess the efficacy of dronedarone versus placebo on AF/AFL-related symptoms. To assess the efficacy of dronedarone versus placebo on ventricular rate control in case of AF/AFL recurrence.

NCT ID: NCT00259012 Completed - Clinical trials for Gastroesophageal Reflux

Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months.

NCT ID: NCT00258934 Completed - Influenza Clinical Trials

Immunogenicity Study of the Influenza Vaccine in Adults

Start date: September 2005
Phase: Phase 2
Study type: Interventional

All marketed influenza vaccines are injected by the intramuscular (IM) route. This study will test whether an influenza vaccine is effective when injected by a route other than into the muscle. In order to prove this, the amount of antibodies in the blood will be measured before and after vaccination. In addition, the safety of both influenza vaccines will be tested by evaluating all serious reactions occurring after vaccination. The vaccine injected in this study is similar to the sponsor's marketed intramuscular influenza vaccine (Vaxigrip). In addition, the safety of both influenza vaccines administered by different routes will be tested by evaluating all adverse events and especially all serious reactions. Primary Objective: To demonstrate and compare the immune response of an influenza vaccine after a single dose when administered by different routes. Secondary Objectives: To describe the compliance of the immunogenicity of the vaccine with the European Medicine Agency (EMEA) after the first injection.

NCT ID: NCT00258557 Completed - HIV Clinical Trials

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy, safety and tolerability of TMC114/r versus Kaletra (a combination pill of lopinavir and ritonavir, ("lpv/rtv") in HIV-1 infected patients who have never been treated with anti-retroviral medications (referred to as "treatment-naïve" patients).

NCT ID: NCT00257608 Completed - Clinical trials for Non-Small Cell Lung Cancer

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

Start date: January 2006
Phase: Phase 3
Study type: Interventional

This is a Phase IIIb, multicenter, randomized, placebo-controlled trial to evaluate the safety and efficacy of chemotherapy+bevacizumab followed by bevacizumab+erlotinib versus bevacizumab+erlotinib placebo in subjects with locally advanced or metastatic NSCLC.